UC San Diego engineers have developed an ultra-sensitive sensor made with graphene that can detect extraordinarily low concentrations of lead ions in water.
The Windreich Department of Artificial Intelligence (AI) and Human Health at the Icahn School of Medicine at Mount Sinai announced a transformative $1.95 million gift from Schmidt Sciences to create The Eric and Wendy Schmidt AI in Human Health Fellowship Program.
A research study led by a multidisciplinary team of scientists at Roswell Park Comprehensive Cancer Center details evidence on the therapeutic efficacy of a compound that targets a key genetic feature of pancreatic cancer.
As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients can benefit from groundbreaking therapies.
Theoretical predictions have been confirmed with the discovery of an outflow of molecular gas from a quasar when the Universe was less than a billion years old.
A new study of data from veterans who had tried many depression treatments but still had severe symptoms suggests a series of intravenous doses of ketamine gave many at least partial relief. For a minority, it led to full remission.
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs), according to a laboratory study led by researchers at the Johns Hopkins Kimmel Cancer Center.
An international team that includes Rutgers University–New Brunswick scientists has developed a new method to make and manipulate a widely studied class of high-temperature superconductors.
A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer.
Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large phase 3 clinical trial reported today at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in San Francisco, California.
In an advance for cultivated meat technology, researchers have developed bovine muscle stem cells that produce their own growth factors, eliminating the need to add the expensive ingredient in the growth media.
Srikanth Singamaneni and Barani Raman, both professors in the McKelvey School of Engineering at Washington University in St. Louis, led a team that harnessed the power of specially made nanostructures to enhance the neural response in a locust's brain to specific odors and to improve their identification of those odors.
Working with mammalian retinal cells, neuroscientists at Johns Hopkins Medicine have shown that, unlike most light-sensing cells (photoreceptors) in the retina, one special type uses two different pathways at the same time to transmit electrical “vision” signals to the brain.
Emerging research from the Department of Energy’s Princeton Plasma Physics Laboratory (PPPL) suggests it may be easier to use fusion as a power source if liquid lithium is applied to the internal walls of the device housing the plasma.
In a few years, popcorn could become a standard element in science classrooms across Illinois and the nation. With funding from a new USDA grant, a University of Illinois Urbana-Champaign crop scientist and collaborating educators are developing a popcorn-based curriculum to reinforce concepts around agricultural science, artificial intelligence, biotechnology, computer science, genomics, research methods, and more for 4-H and high school students.
A team at NYU Tandon School of Engineering will kick off the second phase of an ambitious research project that aims to transform navigation and accessibility for many of the 285 million people with blindness and low vision (pBLV) worldwide.
A Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person’s white blood cells with a single drop of blood, similar to the way glucometers rapidly scan for blood sugar levels. T
Researchers at the National Eye Institute (NEI) have improved a crucial step in the production of retinal pigment epithelium (RPE), a tissue they grow in the lab from patient blood cells and are testing in a clinical trial as treatment for age-related macular degeneration (AMD).
A civil engineer at the University of Pittsburgh is applying his expertise in bridges and infrastructure to develop new materials that better treat spinal injury, repair, and recovery.
A new study in Cell Metabolism by a team from the Monell Chemical Senses Center unravels the internal neural wiring of separate fat and sugar craving pathways in a mouse model. However, combining these pathways overly triggers a desire to eat more than usual.
After children experienced severe traumatic brain injury, the infusion of bone marrow mononuclear cells derived from the patient’s own bones led to less time spent in intensive care, less intense therapy, and, significantly, the structural preservation of white matter, which constitutes about half the total volume of the brain, according to new research from UTHealth Houston.
UC Davis Health and Kaiser Permanente Division of Research received a $24 million grant from the National Institute on Aging, part of the NIH, to continue the Study of Healthy Aging in African Americans (STAR).
The rising cost of health insurance is an ongoing concern in the United States. New research from the Friedman School of Nutrition Science and Policy at Tufts University shows that increasing health insurance costs are eating up a growing proportion of worker’s compensation, and have been a major factor in both flattening wages and increasing income inequality over the past 30 years.
An Indiana University biologist has been awarded $2.8 million from the National Institutes of Health to advance research on DNA folding errors, which have been traced to a wide variety of diseases, including genetic disorders that can cause birth defects or problems with wound healing, as well as certain types of cancer.
Georgia Tech researchers have engineered one of the world’s first yeast cells able to harness energy from light, expanding our understanding of the evolution of this trait — and paving the way for advancements in biofuel production and cellular aging.
Using artificial intelligence to scan surgery patients’ medical records for signs of risky drinking might help spot those whose alcohol use raises their risk of problems during and after an operation, a new study suggests.
A Johns Hopkins Children’s Center study of children and youth with diabetes concludes that so-called autonomous artificial intelligence (AI) diabetic eye exams significantly increase completion rates of screenings designed to prevent potentially blinding diabetes eye diseases (DED).
Researchers at the University of California San Diego have developed a neural implant that provides information about activity deep inside the brain while sitting on its surface.
In a real-world setting, analysis showed that risk of infection and severe illness was significantly lower for those who were vaccinated against COVID-19, and cardiac conditions did not increase
Sleep is a fundamental need, just like food or water. “You’ll die without it,” said Keith Hengen, an assistant professor of biology at Washington University in St. Louis. But what does sleep actually accomplish? For years, the best researchers could say is that sleep reduces sleepiness — hardly a satisfying explanation for a basic requirement of life.
New York, NY [January 4, 2023]—In a milestone study, researchers from the Icahn School of Medicine at Mount Sinai have harnessed the power of artificial intelligence (AI) to enhance the assessment of the heart’s right ventricle, which sends blood to the lungs.
Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community cancer centers, but patients treated in this setting may be less likely to survive, according to new research by investigators from the Johns Hopkins Kimmel Cancer Center and its Head and Neck Cancer Center.
Researchers at Washington University School of Medicine in St. Louis have determined how Eastern equine encephalitis virus attaches to a receptor it uses to enter and infect cells. The findings laid the groundwork for a receptor decoy molecule that protects mice from encephalitis caused by the virus.
Driven by the need for a better way to prioritize targets for drug development, the Icahn School of Medicine at Mount Sinai has led the development of a novel “genetic priority score” (GPS) that will integrate various types of human genetic data into a single easy-to-interpret score. The findings were described in the January 3 online issue of Nature Genetics [DOI: 10.1038/s41588-023-01609-2].
Studies have shown that drugs have an increased likelihood of success in clinical trials when the genes they target have been demonstrated to have genetic support. The new tool integrates multiple lines of genetic evidence to prioritize these drug targets.
Researchers developed an artificial intelligence tool to quickly analyze gene activities in medical images and provide single-cell insight into diseases in tissues and tissue microenvironments.
Discover the first images of cytonemes during mammalian neural development, serving as express routes to establish morphogen gradients and tissue patterning.
Scientists at the Johns Hopkins University School of Medicine and the National Institutes of Health have identified a protein in the visual system of mice that appears to be key for stabilizing the body’s circadian rhythms by buffering the brain’s response to light.
Researchers employ common plastics to kickstart radical chain reactions, creating a way to reuse plastic waste while improving process safety and efficiency.
Frequent insulin injections are an unpleasant, albeit necessary reality for many patients with type 1 diabetes. However, new technology could create a different reality for these patients by treating the disease in one fell swoop.
Using lab-made cells, Harvard Med researchers identify how the immune system neutralizes herpesvirus.
Study maps, for the first time, the maneuvers used by virus and host in the cell nucleus.
Findings could inform design of new treatments for herpes and other viruses that replicate in the same way.